Skip to main content
Clinical Trials/DRKS00004502
DRKS00004502
Completed
N/A

on-interventional study to analyse the efectiveness and tolerance of chemotherapy with Docetaxel NC(R) or Doce NC (R) during the treatment of breast cancer and prostate cancer as an application for the daily routine

eocorp GmbH0 sites450 target enrollmentDecember 14, 2012

Overview

Phase
N/A
Intervention
Not specified
Conditions
C50
Sponsor
eocorp GmbH
Enrollment
450
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 14, 2012
End Date
November 1, 2014
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
eocorp GmbH

Eligibility Criteria

Inclusion Criteria

  • Histological backed prostate carcinoma or breast cancer, Age over 18 Years, signed patient informed consent, therapy in a practice, which belongs to BNGO or IQUO.

Exclusion Criteria

  • Pregnancy, other malignant diseases in the last 5 years, malignant compliance

Outcomes

Primary Outcomes

Not specified

Similar Trials